CHEK2 and prostate cancer: In this study, the role of AMPK/mTOR signaling pathway and the interplay with Chk2 in apoptosis have been identified in nitroxoline-mediated anticancer effect in both hormone-sensitive and hormone-refractory prostate cancer cells.